Form 4 for ABT Abbott Laboratories
Accepted 2022-09-09 00:00:00 ET · period of report 2022-09-08 · accession 0001415889-22-009508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-09 | 2022-09-08 | ABT | MANNING JOSEPH J | EVP | M - OptEx | $44.40 | +23.0K | 76.3K | +43% | +$1.02M |
| D | 2022-09-09 | 2022-09-08 | ABT | MANNING JOSEPH J | EVP | S - Sale+OE | $107.00 | -23.0K | 53.2K | -30% | -$2.46M |
| D | 2022-09-09 | 2022-09-08 | ABT | MANNING JOSEPH J | EVP | M - OptEx | $0.00 | -23.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-09-08 | M | A | 23,008 | $44.40 | 76,253 | D | — | — | |
| 2 | Common | Common shares without par value | 2022-09-08 | S | D | 23,008 | $107.00 | 53,245 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2022-09-08 | M | D | 23,008 | $0.00 | 0 | D | $44.40 · 2020-02-17 to 2027-02-16 | 23,008 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |